Theravance Biopharma (TBPH) Shares Outstanding (Entity) (2013 - 2026)
Theravance Biopharma's Shares Outstanding (Entity) was 51.89 million in Q2 2026, up 3.0% from 50.36 million a year earlier and up 0.7% from the prior quarter.
Theravance Biopharma (TBPH) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Entity) at Theravance Biopharma came in at 51.07 million, up 3.2% from FY2024.
- Shares Outstanding (Entity) shows a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Entity) was 49.47 million in FY2024 (+2.9%), 48.09 million in FY2023 (-26.3%), 65.23 million in FY2022 (-12.4%) and 74.44 million in FY2021 (+15.7%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) since Q2 2023.
- Compared with a year earlier, Shares Outstanding (Entity) has increased for seven straight quarters, with growth averaging 2.2% over the last eight quarters.
- The best year-over-year quarter for Shares Outstanding (Entity) over five years was Q1 2022 (growth of 16.7%); the worst was Q2 2023 (a decline of 29.7%).
- Per Business Quant data, TBPH's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 51.52 million (Q1 2026), 51.07 million (Q4 2025) and 50.67 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 51.89 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.89 Mn |
| Mar 31, 2026 | 51.52 Mn |
| Dec 31, 2025 | 51.07 Mn |
| Sep 30, 2025 | 50.67 Mn |
| Jun 30, 2025 | 50.36 Mn |
| Mar 31, 2025 | 50.00 Mn |
| Dec 31, 2024 | 49.47 Mn |
| Sep 30, 2024 | 49.17 Mn |
| Jun 30, 2024 | 48.92 Mn |
| Mar 31, 2024 | 48.57 Mn |
| Dec 31, 2023 | 48.09 Mn |
| Sep 30, 2023 | 50.82 Mn |
| Jun 30, 2023 | 53.69 Mn |
| Mar 31, 2023 | 60.54 Mn |
| Dec 31, 2022 | 65.23 Mn |
| Sep 30, 2022 | 67.37 Mn |
| Jun 30, 2022 | 76.43 Mn |
| Mar 31, 2022 | 76.08 Mn |
| Dec 31, 2021 | 74.44 Mn |
| Sep 30, 2021 | 73.70 Mn |
Theravance Biopharma Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TBPH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();